NEW On-Demand Webinar - released November 2025
The Florida Society of Pathologists (FSP), in partnership with AstraZeneca, invites you to watch an important and timely on-demand webinar focused on the role of molecular biomarker testing in advanced breast cancer, with an emphasis on hormone receptor–positive, HER2-negative disease. This webinar provides practical insights into how current NCCN guidelines inform testing and treatment strategies and highlight both established and emerging testing methodologies. Whether you work in an academic center or a community practice, this webinar will equip you with knowledge to support meaningful contributions to breast cancer care.
There is no CME for this recorded webinar.